Molecular Express SBIR II Funding
Molecular Express announces award of SBIR Phase II funding from the National Institute of Allergy and Infectious Diseases Advanced Technology program to develop a genital herpes vaccine RANCHO DOMINGU...
User Menu
Topics
Top Story
Molecular Express SBIR II Funding
Molecular Express announces award of SBIR Phase II funding from the National Institute of Allergy and...
SBIR Phase I Funding
SBIR Phase I Funding Wednesday, 18 February 2009 16:46 Molecular Express announces...